Heart regeneration after myocardial infarction using synthetic biomaterials

Journal of Controlled Release

Volumn 203, Issue , 2015, Pages 23-38

  Pascual Gil, S ^a   Garbayo, E ^a   Diaz Herraez P ^a   Prosper, F ^b,c   Blanco Prieto, M J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cell therapy; Clinical trials; Delivery systems; Myocardial infarction; Protein therapy; Synthetic biomaterials; Tissue engineering

Indexed keywords

BIOLOGICAL MATERIALS; BIOMATERIALS; CARDIOLOGY; CELLS; CYTOLOGY; HEART; PROTEINS; REPAIR; TISSUE; TISSUE ENGINEERING;

CELL THERAPY; CLINICAL TRIAL; DELIVERY SYSTEMS; MYOCARDIAL INFARCTION; SYNTHETIC BIOMATERIALS;

CELL ENGINEERING;

BIOMATERIAL; LIPOSOME; NANOFIBER; NANOPARTICLE; PROTEIN; DELAYED RELEASE FORMULATION; SIGNAL PEPTIDE;

CELL THERAPY; CLINICAL TRIAL (TOPIC); DRUG DELIVERY SYSTEM; HEART; HEART INFARCTION; HUMAN; HYDROGEL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REGENERATION; REVIEW; TISSUE ENGINEERING; ANIMAL; BIOLOGICAL THERAPY; CHEMISTRY; DELAYED RELEASE FORMULATION; HEART MUSCLE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATIVE MEDICINE; TISSUE SCAFFOLD;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HEART; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; REGENERATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84922748559     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.02.009     Document Type: Review

References (155)

1. S. Mendis, P. Puska, and B. Norrving Global Atlas on Cardiovascular Disease Prevention and Control 2011 World Health Organization Genebra
2. K. Kurrelmeyer, D. Kalra, B. Bozkurt, F. Wang, Z. Dibbs, and Y. Seta Cardiac remodeling as a consequence and cause of progressive heart failure Clin. Cardiol. 21 1998 I14 I19 (http://www.ncbi.nlm.nih.gov/pubmed/9853190, accessed May 15, 2014)
3. X. Sun, and Z. Jia A brief review of biomarkers for preventing and treating cardiovascular diseases J. Cardiovasc. Dis. Res. 3 2012 251 254 10.4103/0975-3583.102688
4. Y. Toyoda, T.S. Guy, and A. Kashem Present status and future perspectives of heart transplantation Circ. J. 77 2013 1097 1110 (http://www.ncbi.nlm.nih.gov/pubmed/23614963, accessed May 15, 2014)
5. P. Diaz-Herraez, S. Pascual-Gil, E. Garbayo, T. Simon-Yarza, F. Prosper, and M. Blanco-Prieto Cardiac drug delivery Y. Rosen, Drug Deliv. An Integr. Clin. Eng. Approach 2014 CRC Press Taylor & Francis Group
6. M. Fornasini, J. Yarzebski, D. Chiriboga, D. Lessard, F.A. Spencer, and P. Aurigemma Contemporary trends in evidence-based treatment for acute myocardial infarction Am. J. Med. 123 2010 166 172 10.1016/j.amjmed.2009.06.031
7. J.P. Hellermann, T.Y. Goraya, S.J. Jacobsen, S.A. Weston, G.S. Reeder, and B.J. Gersh Incidence of heart failure after myocardial infarction: is it changing over time? Am. J. Epidemiol. 157 2003 1101 1107 (http://www.ncbi.nlm.nih.gov/pubmed/12796046, accessed May 15, 2014)
8. J.C. Sy, and M.E. Davis Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers J. Cardiovasc. Transl. Res. 3 2010 461 468 10.1007/s12265-010-9210-x
9. O. Bergmann, R.D. Bhardwaj, S. Bernard, S. Zdunek, F. Barnabé-Heider, and S. Walsh Evidence for cardiomyocyte renewal in humans Science 324 2009 98 102 10.1126/science.1164680
10. F. Braunschweig, M.R. Cowie, and A. Auricchio What are the costs of heart failure? Europace 13 Suppl. 2 2011 ii13 ii17 10.1093/europace/eur081
11. A.M. van der Laan, J.J. Piek, and N. van Royen Targeting angiogenesis to restore the microcirculation after reperfused MI Nat. Rev. Cardiol. 6 2009 515 523 10.1038/nrcardio.2009.103
12. S.A. Doppler, M.-A. Deutsch, R. Lange, and M. Krane Cardiac regeneration: current therapies - future concepts J. Thorac. Dis. 5 2013 683 697 10.3978/j.issn. 2072-1439.2013.08.71
13. E. Meng, and T. Hoang Micro- and nano-fabricated implantable drug-delivery systems Ther. Deliv. 3 2012 1457 1467 10.4155/tde.12.132
14. C. Cochain, K.M. Channon, and J.S. Silvestre Angiogenesis in the infarcted myocardium Antioxid. Redox. Signal. 18 2013 1100 1113 10.1089/ars.2012.4849
15. V. Grimaldi, F.P. Mancini, A. Casamassimi, M. Al-Omran, A. Zullo, and T. Infante Potential benefits of cell therapy in coronary heart disease J. Cardiol. 62 2013 267 276 10.1016/j.jjcc.2013.05.017
16. M. Ieda, J.-D. Fu, P. Delgado-Olguin, V. Vedantham, Y. Hayashi, and B.G. Bruneau Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors Cell 142 2010 375 386 10.1016/j.cell.2010.07.002
17. A. Bernal, and B.G. Gálvez The potential of stem cells in the treatment of cardiovascular diseases Stem Cell Rev. 9 2013 814 832 10.1007/s12015-013-9461-4
18. C.L. Hastings, E.T. Roche, E. Ruiz-Hernandez, K. Schenke-Layland, C.J. Walsh, and G.P. Duffy Drug and cell delivery for cardiac regeneration Adv. Drug Deliv. Rev. 2014 10.1016/j.addr.2014.08.006
19. A.M. Smits, P. van Vliet, R.J. Hassink, M.-J. Goumans, and P.A. Doevendans The role of stem cells in cardiac regeneration J. Cell. Mol. Med. 9 2005 25 36 http://www.ncbi.nlm.nih.gov/pubmed/15784162 (accessed June 16, 2014)
20. S.K. Sanganalmath, and R. Bolli Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions Circ. Res. 113 2013 810 834 10.1161/CIRCRESAHA.113.300219
21. C.C. Sheng, L. Zhou, and J. Hao Current stem cell delivery methods for myocardial repair BioMed Res. Int. 2013 2013 547902 10.1155/2013/547902
22. R.M. Kanashiro-Takeuchi, I.H. Schulman, and J.M. Hare Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration J. Mol. Cell. Cardiol. 51 2011 619 625 10.1016/j.yjmcc.2011.05.015
23. P. Anversa, J. Kajstura, M. Rota, and A. Leri Regenerating new heart with stem cells J. Clin. Invest. 123 2013 62 70 10.1172/JCI63068
24. I.H. Schulman, and J.M. Hare Key developments in stem cell therapy in cardiology Regen. Med. 7 2012 17 24 (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3604894&tool=pmcentrez&rendertype=abstract, accessed June 16, 2014)
25. J.M.I.H. Gho, G.J.M. Kummeling, S. Koudstaal, S.J. Jansen Of Lorkeers, P.A. Doevendans, and F.W. Asselbergs Cell therapy, a novel remedy for dilated cardiomyopathy? A systematic review J. Card. Fail. 19 2013 494 502 10.1016/j.cardfail.2013.05.006
26. N. Takehara Cell therapy for cardiovascular regeneration Ann. Vasc. Dis. 6 2013 137 144 10.3400/avd.ra.13.00019
27. M. Gnecchi, Z. Zhang, A. Ni, and V.J. Dzau Paracrine mechanisms in adult stem cell signaling and therapy Circ. Res. 103 2008 1204 1219 10.1161/CIRCRESAHA.108.176826
28. A.G.-E. Ibrahim, K. Cheng, and E. Marbán Exosomes as critical agents of cardiac regeneration triggered by cell therapy Stem Cell Rep. 2 2014 606 619 10.1016/j.stemcr.2014.04.006
29. F.R. Formiga, E. Tamayo, T. Simón-Yarza, B. Pelacho, F. Prósper, and M.J. Blanco-Prieto Angiogenic therapy for cardiac repair based on protein delivery systems Heart Fail. Rev. 17 2012 449 473 10.1007/s10741-011-9285-8
30. S.M. Jay, and R.T. Lee Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair Circ. Res. 113 2013 933 943 10.1161/CIRCRESAHA.113.300215
31. M.T. Lam, and J.C. Wu Biomaterial applications in cardiovascular tissue repair and regeneration Expert. Rev. Cardiovasc. Ther. 10 2012 1039 1049 10.1586/erc.12.99
32. A.Y. Cheng, and A.J. García Engineering the matrix microenvironment for cell delivery and engraftment for tissue repair Curr. Opin. Biotechnol. 24 2013 864 871 10.1016/j.copbio.2013.04.005
33. R. Ravichandran, J.R. Venugopal, S. Sundarrajan, S. Mukherjee, and S. Ramakrishna Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease Int. J. Nanomedicine 7 2012 5969 5994 10.2147/IJN.S37575
34. H.-I. Chang, and Y. Wang Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 2011 InTech
35. E. Garbayo, J. Gavira, G. Abizanda, B. Pelacho, E. Albiasu, F. Prosper, et al., Controlled Intramyocardial Delivery of NRG-1 and FGF-1 From Biodegradable Microparticles in a Large Preclinical Myocardial Infarction Model, submitted.
36. F.R. Formiga, E. Garbayo, P. Díaz-Herráez, G. Abizanda, T. Simón-Yarza, and E. Tamayo Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia Eur. J. Pharm. Biopharm. 85 2013 665 672 10.1016/j.ejpb.2013.02.017
37. P. Díaz-Herráez, E. Garbayo, T. Simón-Yarza, F.R. Formiga, F. Prosper, and M.J. Blanco-Prieto Adipose-derived stem cells combined with neuregulin-1 delivery systems for heart tissue engineering Eur. J. Pharm. Biopharm. 85 2013 143 150 10.1016/j.ejpb.2013.03.022
38. T.K. Dash, and V.B. Konkimalla Poly-ε-caprolactone based formulations for drug delivery and tissue engineering: a review J. Control. Release 158 2012 15 33 10.1016/j.jconrel.2011.09.064
39. R. Lakshmanan, U.M. Krishnan, and S. Sethuraman Polymeric scaffold aided stem cell therapeutics for cardiac muscle repair and regeneration Macromol. Biosci. 13 2013 1119 1134 10.1002/mabi.201300223
40. C. Tang, X. Shao, B. Sun, W. Huang, and X. Zhao The effect of self-assembling peptide RADA16-I on the growth of human leukemia cells in vitro and in nude mice Int. J. Mol. Sci. 10 2009 2136 2145 10.3390/ijms10052136
41. S. Zhang, F. Gelain, and X. Zhao Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures Semin. Cancer Biol. 15 2005 413 420 10.1016/j.semcancer.2005.05.007
42. J. Du, S. Wang, H. You, and X. Zhao Understanding the toxicity of carbon nanotubes in the environment is crucial to the control of nanomaterials in producing and processing and the assessment of health risk for human: a review Environ. Toxicol. Pharmacol. 36 2013 451 462 10.1016/j.etap.2013.05.007
43. B.D. Ulery, L.S. Nair, and C.T. Laurencin Biomedical applications of biodegradable polymers J. Polym. Sci. B Polym. Phys. 49 2011 832 864 10.1002/polb.22259
44. A.K.A. Silva, C. Richard, M. Bessodes, D. Scherman, and O.-W. Merten Growth factor delivery approaches in hydrogels Biomacromolecules 10 2009 9 18 10.1021/bm801103c
45. L.-W. Xia, R. Xie, X.-J. Ju, W. Wang, Q. Chen, and L.-Y. Chu Nano-structured smart hydrogels with rapid response and high elasticity Nat. Commun. 4 2013 2226 10.1038/ncomms3226
46. K.L. Fujimoto, K. Tobita, W.D. Merryman, J. Guan, N. Momoi, and D.B. Stolz An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction J. Am. Coll. Cardiol. 49 2007 2292 2300 10.1016/j.jacc.2007.02.050
47. K.L. Fujimoto, Z. Ma, D.M. Nelson, R. Hashizume, J. Guan, and K. Tobita Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium Biomaterials 30 2009 4357 4368 10.1016/j.biomaterials.2009.04.055
48. X.-J. Jiang, T. Wang, X.-Y. Li, D.-Q. Wu, Z.-B. Zheng, and J.-F. Zhang Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction J. Biomed. Mater. Res. A 90 2009 472 477 10.1002/jbm.a.32118
49. T. Wang, D.-Q. Wu, X.-J. Jiang, X.-Z. Zhang, X.-Y. Li, and J.-F. Zhang Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling Eur. J. Heart Fail. 11 2009 14 19 10.1093/eurjhf/hfn009
50. K. Kadner, S. Dobner, T. Franz, D. Bezuidenhout, M.S. Sirry, and P. Zilla The beneficial effects of deferred delivery on the efficiency of hydrogel therapy post myocardial infarction Biomaterials 33 2012 2060 2066 10.1016/j.biomaterials.2011.11.031
51. S. Ren, X. Jiang, Z. Li, Y. Wen, D. Chen, and X. Li Physical properties of poly(N-isopropylacrylamide) hydrogel promote its effects on cardiac protection after myocardial infarction J. Int. Med. Res. 40 2012 2167 2182 (http://www.ncbi.nlm.nih.gov/pubmed/23321174, accessed June 17, 2014)
52. S.T. Wall, C.-C. Yeh, R.Y.K. Tu, M.J. Mann, and K.E. Healy Biomimetic matrices for myocardial stabilization and stem cell transplantation J. Biomed. Mater. Res. A 95 2010 1055 1066 10.1002/jbm.a.32904
53. X.-Y. Li, T. Wang, X.-J. Jiang, T. Lin, D.-Q. Wu, and X.-Z. Zhang Injectable hydrogel helps bone marrow-derived mononuclear cells restore infarcted myocardium Cardiology 115 2010 194 199 10.1159/000281840
54. T.D. Johnson, and K.L. Christman Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction Expert Opin. Drug Deliv. 10 2013 59 72 10.1517/17425247.2013.739156
55. T. Wang, X.-J. Jiang, Q.-Z. Tang, X.-Y. Li, T. Lin, and D.-Q. Wu Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction Acta Biomater. 5 2009 2939 2944 10.1016/j.actbio.2009.04.040
56. J.M. Singelyn, and K.L. Christman Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices J. Cardiovasc. Transl. Res. 3 2010 478 486 10.1007/s12265-010-9202-x
57. M. Habib, K. Shapira-Schweitzer, O. Caspi, A. Gepstein, G. Arbel, and D. Aronson A combined cell therapy and in-situ tissue-engineering approach for myocardial repair Biomaterials 32 2011 7514 7523 10.1016/j.biomaterials.2011.06.049
58. C. Bearzi, C. Gargioli, D. Baci, O. Fortunato, K. Shapira-Schweitzer, and O. Kossover PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium Cell Death Dis. 5 2014 e1053 10.1038/cddis.2014.12
59. H. Wang, Z. Liu, D. Li, X. Guo, F.K. Kasper, and C. Duan Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction J. Cell. Mol. Med. 16 2012 1310 1320 10.1111/j.1582-4934.2011.01409.x
60. V.F.M. Segers, and R.T. Lee Local delivery of proteins and the use of self-assembling peptides Drug Discov. Today 12 2007 561 568 10.1016/j.drudis.2007.05.003
61. S. Zhang Fabrication of novel biomaterials through molecular self-assembly Nat. Biotechnol. 21 2003 1171 1178 10.1038/nbt874
62. S. Zhang, T.C. Holmes, C.M. DiPersio, R.O. Hynes, X. Su, and A. Rich Self-complementary oligopeptide matrices support mammalian cell attachment Biomaterials 16 1995 1385 1393 (http://www.ncbi.nlm.nih.gov/pubmed/8590765, accessed June 17, 2014)
63. M.E. Davis, J.P.M. Motion, D.A. Narmoneva, T. Takahashi, D. Hakuno, and R.D. Kamm Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells Circulation 111 2005 442 450 10.1161/01.CIR.0000153847.47301.80
64. Y.-D. Lin, M.-L. Yeh, Y.-J. Yang, D.-C. Tsai, T.-Y. Chu, and Y.-Y. Shih Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs Circulation 122 2010 S132 S141 10.1161/CIRCULATIONAHA.110.939512
65. B.C. Heng, H.K. Haider, E.K.-W. Sim, T. Cao, and S.C. Ng Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro Cardiovasc. Res. 62 2004 34 42 10.1016/j.cardiores.2003.12.022
66. X. Cui, H. Xie, H. Wang, H. Guo, J. Zhang, and C. Wang Transplantation of mesenchymal stem cells with self-assembling polypeptide scaffolds is conducive to treating myocardial infarction in rats Tohoku J. Exp. Med. 222 2010 281 289 (http://www.ncbi.nlm.nih.gov/pubmed/21139379, accessed June 17, 2014)
67. H. Guo, G. Cui, H. Wang, and Y. Tan Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction Biochem. Biophys. Res. Commun. 399 2010 42 48 10.1016/j.bbrc.2010.07.031
68. M. Tokunaga, M.-L. Liu, T. Nagai, K. Iwanaga, K. Matsuura, and T. Takahashi Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction J. Mol. Cell. Cardiol. 49 2010 972 983 10.1016/j.yjmcc.2010.09.015
69. X. Li, J. Zhou, Z. Liu, J. Chen, S. Lü, and H. Sun A PNIPAAm-based thermosensitive hydrogel containing SWCNTs for stem cell transplantation in myocardial repair Biomaterials 35 2014 5679 5688 10.1016/j.biomaterials.2014.03.067
70. J. Wu, F. Zeng, X.-P. Huang, J.C.-Y. Chung, F. Konecny, and R.D. Weisel Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel Biomaterials 32 2011 579 586 10.1016/j.biomaterials.2010.08.098
71. J.C. Garbern, E. Minami, P.S. Stayton, and C.E. Murry Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium Biomaterials 32 2011 2407 2416 10.1016/j.biomaterials.2010.11.075
72. D. Projahn, S. Simsekyilmaz, S. Singh, I. Kanzler, B.K. Kramp, and M. Langer Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction J. Cell. Mol. Med. 18 2014 790 800 10.1111/jcmm.12225
73. A.S. Salimath, E.A. Phelps, A.V. Boopathy, P. Che, M. Brown, and A.J. García Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats PLoS One 7 2012 e50980 10.1371/journal.pone.0050980
74. S. Koudstaal, M.M.C. Bastings, D.A.M. Feyen, C.D. Waring, F.J. van Slochteren, and P.Y.W. Dankers Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart J. Cardiovasc. Transl. Res. 7 2014 232 241 10.1007/s12265-013-9518-4
75. T. Wang, X.-J. Jiang, T. Lin, S. Ren, X.-Y. Li, and X.-Z. Zhang The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel Biomaterials 30 2009 4161 4167 10.1016/j.biomaterials.2009.04.033
76. P.C.H. Hsieh, M.E. Davis, J. Gannon, C. MacGillivray, and R.T. Lee Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers J. Clin. Invest. 116 2006 237 248 10.1172/JCI25878
77. P.C.H. Hsieh, C. MacGillivray, J. Gannon, F.U. Cruz, and R.T. Lee Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity Circulation 114 2006 637 644 10.1161/CIRCULATIONAHA.106.639831
78. H. Guo, G. Cui, J. Yang, C. Wang, J. Zhu, and L. Zhang Sustained delivery of VEGF from designer self-assembling peptides improves cardiac function after myocardial infarction Biochem. Biophys. Res. Commun. 424 2012 105 111 10.1016/j.bbrc.2012.06.080
79. V.F.M. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 2007 1683 1692 10.1161/CIRCULATIONAHA.107.718718
80. J.H. Kim, Y. Jung, S.-H. Kim, K. Sun, J. Choi, and H.C. Kim The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides Biomaterials 32 2011 6080 6088 10.1016/j.biomaterials.2011.05.003
81. M.J. Webber, X. Han, S.N.P. Murthy, K. Rajangam, S.I. Stupp, and J.W. Lomasney Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases J. Tissue Eng. Regen. Med. 4 2010 600 610 10.1002/term.273
82. Y.-Y. He, Y. Wen, X.-X. Zheng, and X.-J. Jiang Intramyocardial delivery of HMGB1 by a novel thermosensitive hydrogel attenuates cardiac remodeling and improves cardiac function after myocardial infarction J. Cardiovasc. Pharmacol. 61 2013 283 290 10.1097/FJC.0b013e31827ecd50
83. T.C. Laurent, and J.R. Fraser Hyaluronan FASEB J. 6 1992 2397 2404 (http://www.ncbi.nlm.nih.gov/pubmed/1563592, accessed June 17, 2014)
84. J.W. MacArthur, B.P. Purcell, Y. Shudo, J.E. Cohen, A. Fairman, and A. Trubelja Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction Circulation 128 2013 S79 S86 10.1161/CIRCULATIONAHA.112.000343
85. D. Castellano, M. Blanes, B. Marco, I. Cerrada, and A. Ruiz-Saurí A comparison of electrospun polymers reveals poly(3-hydroxybutyrate) fiber as a superior scaffold for cardiac repair Stem Cells Dev. 2014 10.1089/scd.2013.0578
86. K.L. Fujimoto, J. Guan, H. Oshima, T. Sakai, and W.R. Wagner In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures Ann. Thorac. Surg. 83 2007 648 654 10.1016/j.athoracsur.2006.06.085
87. J. Jin, S.I. Jeong, Y.M. Shin, K.S. Lim, H. soo Shin, and Y.M. Lee Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model Eur. J. Heart Fail. 11 2009 147 153 10.1093/eurjhf/hfn017
88. D. Kai, Q.-L. Wang, H.-J. Wang, M.P. Prabhakaran, Y. Zhang, and Y.-Z. Tan Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model Acta Biomater. 10 2014 2727 2738 10.1016/j.actbio.2014.02.030
89. H. Piao, J.-S. Kwon, S. Piao, J.-H. Sohn, Y.-S. Lee, and J.-W. Bae Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model Biomaterials 28 2007 641 649 10.1016/j.biomaterials.2006.09.009
90. Q. Ke, Y. Yang, J.S. Rana, Y. Chen, J.P. Morgan, and Y.-F. Xiao Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice Sheng Li Xue Bao 57 2005 673 681 (http://www.ncbi.nlm.nih.gov/pubmed/16344890, accessed June 17, 2014)
91. T.C. McDevitt, K.A. Woodhouse, S.D. Hauschka, C.E. Murry, and P.S. Stayton Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair J. Biomed. Mater. Res. A 66 2003 586 595 10.1002/jbm.a.10504
92. R.J. Zdrahala, and I.J. Zdrahala Biomedical applications of polyurethanes: a review of past promises, present realities, and a vibrant future J. Biomater. Appl. 14 1999 67 90 (http://www.ncbi.nlm.nih.gov/pubmed/10405885, accessed June 17, 2014)
93. B. Blumenthal, P. Golsong, A. Poppe, C. Heilmann, C. Schlensak, and F. Beyersdorf Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function Artif. Organs 34 2010 E46 E54 10.1111/j.1525-1594.2009.00937.x
94. R. von Wattenwyl, B. Blumenthal, C. Heilmann, P. Golsong, A. Poppe, and F. Beyersdorf Scaffold-based transplantation of vascular endothelial growth factor-overexpressing stem cells leads to neovascularization in ischemic myocardium but did not show a functional regenerative effect ASAIO J. 58 2012 268 274 10.1097/MAT.0b013e3182523237
95. A. Poppe, P. Golsong, B. Blumenthal, R. von Wattenwyl, P. Blanke, and F. Beyersdorf Hepatocyte growth factor-transfected skeletal myoblasts to limit the development of postinfarction heart failure Artif. Organs 36 2012 238 246 10.1111/j.1525-1594.2011.01328.x
96. S. Yasuda, Y. Goto, T. Baba, T. Satoh, H. Sumida, and S. Miyazaki Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function J. Am. Coll. Cardiol. 36 2000 115 121 (http://www.ncbi.nlm.nih.gov/pubmed/10898422, accessed June 17, 2014)
97. M.-N. Giraud, R. Flueckiger, S. Cook, E. Ayuni, M. Siepe, and T. Carrel Long-term evaluation of myoblast seeded patches implanted on infarcted rat hearts Artif. Organs 34 2010 E184 E192 10.1111/j.1525-1594.2009.00979.x
98. Y. Wang, X.-C. Liu, J. Zhao, X.-R. Kong, R.-F. Shi, and X.-B. Zhao Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization Tex. Heart Inst. J. 36 2009 89 97 (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2676585&tool=pmcentrez&rendertype=abstract, accessed June 17, 2014)
99. E. Fathi, S.M. Nassiri, N. Atyabi, S.H. Ahmadi, M. Imani, and R. Farahzadi Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol-dextran blend hydrogel in an ovine model of acute myocardial infarction J. Tissue Eng. Regen. Med. 7 2013 697 707 10.1002/term.1460
100. + cell homing to the infarcted heart Tissue Eng. 13 2007 2063 2071 10.1089/ten.2006.0013
101. T. Simón-Yarza, A. Rossi, K.H. Heffels, F. Prosper, J. Groll, and M.J. Blanco-Prieto Polymeric electrospun scaffolds: neuregulin encapsulation and biocompatibility studies in a model of myocardial ischemia Tissue Eng. 2015 in press
102. M.N. Ravi Kumar Nano and microparticles as controlled drug delivery devices J. Pharm. Pharm. Sci. 3 2000 234 258 http://www.ncbi.nlm.nih.gov/pubmed/10994037 (accessed June 17, 2014)
103. J.J. Moon, B. Huang, and D.J. Irvine Engineering nano- and microparticles to tune immunity Adv. Mater. 24 2012 3724 3746 10.1002/adma.201200446
104. A.C. Anselmo, and S. Mitragotri Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles J. Control. Release 2014 10.1016/j.jconrel.2014.03.050
105. J. Meng, X. Yang, L. Jia, X.-J. Liang, and C. Wang Impacts of nanoparticles on cardiovascular diseases: modulating metabolism and function of endothelial cells Curr. Drug Metab. 13 2012 1123 1129 (http://www.ncbi.nlm.nih.gov/pubmed/22380015, accessed June 29, 2014)
106. D. Kumar, N. Saini, N. Jain, R. Sareen, and V. Pandit Gold nanoparticles: an era in bionanotechnology Expert Opin. Drug Deliv. 10 2013 397 409 10.1517/17425247.2013.749854
107. J. Yu, K.T. Du, Q. Fang, Y. Gu, S.S. Mihardja, and R.E. Sievers The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat Biomaterials 31 2010 7012 7020 10.1016/j.biomaterials.2010.05.078
108. A.E. Mayfield, E.L. Tilokee, N. Latham, B. McNeill, B.-K. Lam, and M. Ruel The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function Biomaterials 35 2014 133 142 10.1016/j.biomaterials.2013.09.085
109. C. Penna, M.-G. Perrelli, J.-P. Karam, C. Angotti, C. Muscari, and C.N. Montero-Menei Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival J. Cell. Mol. Med. 17 2013 192 204 10.1111/j.1582-4934.2012.01662.x
110. C.-C. Huang, H.-J. Wei, Y.-C. Yeh, J.-J. Wang, W.-W. Lin, and T.-Y. Lee Injectable PLGA porous beads cellularized by hAFSCs for cellular cardiomyoplasty Biomaterials 33 2012 4069 4077 10.1016/j.biomaterials.2012.02.024
111. N. Kamaly, Z. Xiao, P.M. Valencia, A.F. Radovic-Moreno, and O.C. Farokhzad Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Chem. Soc. Rev. 41 2012 2971 3010 10.1039/c2cs15344k
112. V.P. Torchilin Passive and active drug targeting: drug delivery to tumors as an example Handb. Exp. Pharmacol. 2010 10.1007/978-3-642-00477-3-1
113. P. Charoenphol, R.B. Huang, and O. Eniola-Adefeso Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers Biomaterials 31 2010 1392 1402 10.1016/j.biomaterials.2009.11.007
114. M.F. Kiani, H. Yuan, X. Chen, L. Smith, M.W. Gaber, and D.J. Goetz Targeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules Pharm. Res. 19 2002 1317 1322 (http://www.ncbi.nlm.nih.gov/pubmed/12403068, accessed June 17, 2014)
115. R.M. Abra, and C.A. Hunt Liposome disposition in vivo. III. Dose and vesicle-size effects Biochim. Biophys. Acta 666 1981 493 503 (http://www.ncbi.nlm.nih.gov/pubmed/7034780, accessed June 17, 2014)
116. S.M. Moghimi, C.J. Porter, I.S. Muir, L. Illum, and S.S. Davis Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating Biochem. Biophys. Res. Commun. 177 1991 861 866 (http://www.ncbi.nlm.nih.gov/pubmed/2049107, accessed June 17, 2014)
117. J.C. Sy, G. Seshadri, S.C. Yang, M. Brown, T. Oh, and S. Dikalov Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction Nat. Mater. 7 2008 863 868 10.1038/nmat2299
118. G. Ambrosio, L.C. Becker, G.M. Hutchins, H.F. Weisman, and M.L. Weisfeldt Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury Circulation 74 1986 1424 1433 (http://www.ncbi.nlm.nih.gov/pubmed/3779923, accessed June 17, 2014)
119. G. Seshadri, J.C. Sy, M. Brown, S. Dikalov, S.C. Yang, and N. Murthy The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury Biomaterials 31 2010 1372 1379 10.1016/j.biomaterials.2009.10.045
120. S. Aso, H. Ise, M. Takahashi, S. Kobayashi, H. Morimoto, and A. Izawa Effective uptake of N-acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro J. Control. Release 122 2007 189 198 10.1016/j.jconrel.2007.07.003
121. W.D. Gray, P. Che, M. Brown, X. Ning, N. Murthy, and M.E. Davis N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing J. Cardiovasc. Transl. Res. 4 2011 631 643 10.1007/s12265-011-9292-0
122. M.-Y. Chang, Y.-J. Yang, C.-H. Chang, A.C.L. Tang, W.-Y. Liao, and F.-Y. Cheng Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction J. Control. Release 170 2013 287 294 10.1016/j.jconrel.2013.04.022
123. F.R. Formiga, B. Pelacho, E. Garbayo, G. Abizanda, J.J. Gavira, and T. Simon-Yarza Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model J. Control. Release 147 2010 30 37 10.1016/j.jconrel.2010.07.097
124. G.P. Littarru, L. Tiano, R. Belardinelli, and G.F. Watts Coenzyme Q(10), endothelial function, and cardiovascular disease Biofactors. 37 2011 366 373 10.1002/biof.154
125. T. Simón-Yarza, E. Tamayo, C. Benavides, H. Lana, F.R. Formiga, and C.N. Grama Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia Int. J. Pharm. 454 2013 784 790 10.1016/j.ijpharm.2013.04.015
126. F.R. Formiga, B. Pelacho, E. Garbayo, I. Imbuluzqueta, P. Díaz-Herráez, and G. Abizanda Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration J. Control. Release 173 2014 132 139 10.1016/j.jconrel.2013.10.034
127. K.S. Oh, J.Y. Song, S.J. Yoon, Y. Park, D. Kim, and S.H. Yuk Temperature-induced gel formation of core/shell nanoparticles for the regeneration of ischemic heart J. Control. Release 146 2010 207 211 10.1016/j.jconrel.2010.04.014
128. A. Akbarzadeh, R. Rezaei-Sadabady, S. Davaran, S.W. Joo, N. Zarghami, and Y. Hanifehpour Liposome: classification, preparation, and applications Nanoscale Res. Lett. 8 2013 102 10.1186/1556-276X-8-102
129. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160 10.1038/nrd1632
130. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Nanotheranostics and image-guided drug delivery: current concepts and future directions Mol. Pharm. 7 2010 1899 1912 10.1021/mp100228v
131. T.S. Levchenko, W.C. Hartner, and V.P. Torchilin Liposomes for cardiovascular targeting Ther. Deliv. 3 2012 501 514 (http://www.ncbi.nlm.nih.gov/pubmed/22834079, accessed June 17, 2014)
132. T. Harel-Adar, T. Ben Mordechai, Y. Amsalem, M.S. Feinberg, J. Leor, and S. Cohen Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair Proc. Natl. Acad. Sci. U. S. A. 108 2011 1827 1832 10.1073/pnas.1015623108
133. M.S. Mufamadi, V. Pillay, Y.E. Choonara, L.C.Du. Toit, G. Modi, and D. Naidoo A review on composite liposomal technologies for specialized drug delivery J. Drug Deliv. 2011 2011 939851 10.1155/2011/939851
134. G.U. Ruiz-Esparza, J.H. Flores-Arredondo, V. Segura-Ibarra, G. Torre-Amione, M. Ferrari, and E. Blanco The physiology of cardiovascular disease and innovative liposomal platforms for therapy Int. J. Nanomedicine 8 2013 629 640 10.2147/IJN.S30599
135. R. Mathaes, G. Winter, A. Besheer, and J. Engert Influence of particle geometry and PEGylation on phagocytosis of particulate carriers Int. J. Pharm. 465 2014 159 164 10.1016/j.ijpharm.2014.02.037
136. U. Wattendorf, and H.P. Merkle PEGylation as a tool for the biomedical engineering of surface modified microparticles J. Pharm. Sci. 97 2008 4655 4669 10.1002/jps.21350
137. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomedicine 1 2006 297 315 (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2426795&tool=pmcentrez&rendertype=abstract, accessed June 22, 2014)
138. V.E. Armstead, A.G. Minchenko, B. Campbell, and A.M. Lefer P-selectin is up-regulated in vital organs during murine traumatic shock FASEB J. 11 1997 1271 1279 (http://www.ncbi.nlm.nih.gov/pubmed/9409546, accessed June 17, 2014)
139. R.C. Scott, B. Wang, R. Nallamothu, C.B. Pattillo, G. Perez-Liz, and A. Issekutz Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction Biotechnol. Bioeng. 96 2007 795 802 10.1002/bit.21233
140. R.C. Scott, J.M. Rosano, Z. Ivanov, B. Wang, P.L.-G. Chong, and A.C. Issekutz Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function FASEB J. 23 2009 3361 3367 10.1096/fj.08-127373
141. B. Wang, R. Cheheltani, J. Rosano, D.L. Crabbe, and M.F. Kiani Targeted delivery of VEGF to treat myocardial infarction Adv. Exp. Med. Biol. 765 2013 307 314 10.1007/978-1-4614-4989-8-43
142. Y. Yamada, H. Kobayashi, M. Iwasa, S. Sumi, H. Ushikoshi, and T. Aoyama Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits Am. J. Physiol. Heart Circ. Physiol. 304 2013 H1124 H1133 10.1152/ajpheart.00707.2012
143. N. Kaila, and B.E. Thomas Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors Med. Res. Rev. 22 2002 566 601 10.1002/med.10018
144. S. Fukuhara, S. Tomita, T. Nakatani, T. Fujisato, Y. Ohtsu, and M. Ishida Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heart Circ. J. 69 2005 850 857 (http://www.ncbi.nlm.nih.gov/pubmed/15988112, accessed June 17, 2014)
145. D. Srivastava, M. Ieda, J. Fu, and L. Qian Cardiac repair with thymosin β4 and cardiac reprogramming factors Ann. N. Y. Acad. Sci. 1270 2012 66 72 10.1111/j.1749-6632.2012.06696.x
146. T.P. Kraehenbuehl, L.S. Ferreira, A.M. Hayward, M. Nahrendorf, A.J. van der Vlies, and E. Vasile Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction Biomaterials 32 2011 1102 1109 10.1016/j.biomaterials.2010.10.005
147. M.E. Davis, P.C.H. Hsieh, T. Takahashi, Q. Song, S. Zhang, and R.D. Kamm Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction Proc. Natl. Acad. Sci. U. S. A. 103 2006 8155 8160 10.1073/pnas.0602877103
148. M.E. Padin-Iruegas, Y. Misao, M.E. Davis, V.F.M. Segers, G. Esposito, and T. Tokunou Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction Circulation 120 2009 876 887 10.1161/CIRCULATIONAHA.109.852285
149. G. Dubois, V.F.M. Segers, V. Bellamy, L. Sabbah, S. Peyrard, and P. Bruneval Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium J. Biomed. Mater. Res. B Appl. Biomater. 87 2008 222 228 10.1002/jbm.b.31099
150. G. Zhang, Q. Hu, E.A. Braunlin, L.J. Suggs, and J. Zhang Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix Tissue Eng. A 14 2008 1025 1036 10.1089/ten.tea.2007.0289
151. C.A. Holladay, A.M. Duffy, X. Chen, M.V. Sefton, T.D. O'Brien, and A.S. Pandit Recovery of cardiac function mediated by MSC and interleukin-10 plasmid functionalised scaffold Biomaterials 33 2012 1303 1314 10.1016/j.biomaterials.2011.10.019
152. Y. Miyagi, F. Zeng, X.-P. Huang, W.D. Foltz, J. Wu, and A. Mihic Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold Biomaterials 31 2010 7684 7694 10.1016/j.biomaterials.2010.06.048
153. M.E. Davis, P.C.H. Hsieh, A.J. Grodzinsky, and R.T. Lee Custom design of the cardiac microenvironment with biomaterials Circ. Res. 97 2005 8 15 10.1161/01.RES.0000173376.39447.01
154. G. Vunjak-Novakovic, N. Tandon, A. Godier, R. Maidhof, A. Marsano, and T.P. Martens Challenges in cardiac tissue engineering Tissue Eng. B Rev. 16 2010 169 187 10.1089/ten.TEB.2009.0352
155. G. Tarun, B. Ajay, K. Bhawna, K. Sunil, and C. Arsh Current status and future directions of new drug delivery technologies Int. Res. J. Pharm. 2 12 2011 61 68